Sagimet Biosciences Inc.
ID: 7381982Sagimet Biosciences Inc. is a drugs targeting the fatty acid synthase enzyme.
3
Funding Rounds
$185.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Me**** Pa**** | - | - | - |
| Be** Se******** | - | - | - |
| Ge**** Ke**** |
|
- | |
| Ji*** J. Wu | - | - | |
| Go**** Ri***** | - | - | - |
| Ja*** F. Yo*** | - | - | |
| El******* Gr***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Sagimet Biosciences Inc. has raised a total of $105m in funding over 3 rounds.
Key Insights:
- Sagimet Biosciences Inc. , February 2021: $80m
- Sagimet Biosciences Inc. Series E round, August 2019: $25m
- Sagimet Biosciences Inc. funding round, December 2020: $80.02m
Industries
Sagimet Biosciences Inc. is active in the following industries: